Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04545346 · ClinicalTrials.gov registry record · NA
The Potential of a Low Glutamate Diet as a Treatment for Pediatric Epilepsy
A NA study, sponsored by American University.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT04545346: Completed NA study, sponsored by American University.
NCT04545346 is a NA study that has completed, run by American University. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04545346, a NA study, has completed, sponsored by American University.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The study is investigating if following the low glutamate diet for 1 month, as compared to care as usual, can improve seizure frequency, severity, and duration; cognitive functioning; and/or quality of life in children with epilepsy.
Primary Outcome
All families will keep a seizure diary recording the number of daily seizures. This will be used to accurately determine these variables for the last week, which will be recorded on seizure assessment forms.
Interventions
- OTHER Low Glutamate diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2020-10-15 |
| Est. Completion | 2022-06-15 |
| Phase | NA |
What the finished NCT04545346 record still lists
NCT04545346 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Low Glutamate diet is the first listed.
NCT04545346 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04545346 about?
NCT04545346 is a clinical study titled "The Potential of a Low Glutamate Diet as a Treatment for Pediatric Epilepsy". The study is investigating if following the low glutamate diet for 1 month, as compared to care as usual, can improve seizure frequency, severity, and duration; cognitive functioning; and/or quality of life in children with epilepsy.
What is the current status of trial NCT04545346?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2020-10-15. Estimated completion is 2022-06-15.
What interventions are being tested in trial NCT04545346?
The interventions under investigation include: Low Glutamate diet (OTHER).
Who is sponsoring clinical trial NCT04545346?
This trial is sponsored by American University, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04545346's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI